Survey Reveals that HMOs Made Improvements in Quality of Care During 1999
The nonprofit National Committee for Quality Assurance, which helps employers gauge the quality of their health insurance plans, studied clinical quality measures and reported that the industry had made significant gains in 1999. The analysis is based upon 466 health plans that insure about 51 million people. The most noteworthy progress is in improvements in heart-disease prevention and childhood immunizations. The survey also reported areas that need improvement. Two major areas of concern are patients with asthma and preventative medicine (e.g., diabetic-eye exams and cervical-cancer screening). For more information visit www.ncqa.org.
Health at Risk: The Impact of Antimicrobial Resistance From a Global to Local Health Perspective
March 6th 2024Discover the critical role infection preventionists play in combating multidrug-resistant organisms, from the impact on patient care to the challenges of treatment, and the evolving landscape of antimicrobial resistance with Katharine J Hoffman, MPH, CIC.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
FDA Approves Enmetazobactam for Complicated UTIs: A Breakthrough in Antimicrobial Therapy
February 26th 2024Enmetazobactam (Exblifep; Orchid Pharma) has received FDA approval for treating complicated urinary tract infections (cUTIs), offering a promising solution in the battle against antimicrobial resistance.